Target Name: PIGG
NCBI ID: G54872
Review Report on PIGG Target / Biomarker Content of Review Report on PIGG Target / Biomarker
PIGG
Other Name(s): Phosphatidylinositol-glycan biosynthesis class G protein | GPI ethanolamine phosphate transferase 2 (isoform 1) | hGPI7 | NEDHSCA | LAS21 | phosphatidylinositol-glycan biosynthesis class G protein | PIGG_HUMAN | RLGS1930 | GPI ethanolamine phosphate transferase 2 | GPI7 | Phosphatidylinositol glycan, class G | PIGG variant 1 | PRO4405 | phosphatidylinositol glycan anchor biosynthesis class G | EMM | MRT53 | GPI7 homolog | EMM blood group antigen | LAS21 (GPI7) homolog | PIG-G | Phosphatidylinositol glycan anchor biosynthesis class G, transcript variant 1

Structure and Function of PIGGs: Unraveling Cell Signaling and Disease

Phosphatidylinositol-glycan (PIGG) is a class of proteins that play a crucial role in cellular signaling. PIGGs are transmembrane proteins that contain a phosphatidylinositol (PIP) tail and a glycan moiety. They are involved in various cellular processes, including cell signaling, cytoskeletal organization, and cell survival.

One of the key functions of PIGGs is the production of intracellular signaling molecules, such as inositol and diacylglycerol (DAG). These molecules play important roles in cell signaling and are involved in a wide range of cellular processes, including intracellular signaling, cell survival, and cell movement.

PIGGs are involved in many different cellular signaling pathways, including the cell signaling pathway, the protein kinase C (PKC) pathway, and the mitogen-activated protein kinase (MAPK) pathway. They are also involved in the regulation of various cellular processes, including cell adhesion, cell migration, and cell survival.

PIGGs have also been shown to be involved in the development and progression of various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. They have also been shown to be potential drug targets, with several PIGG-related drugs currently in development.

One of the key challenges in studying PIGGs is their complex structure and function. Because they are transmembrane proteins, they are difficult to study in a cell-in-a-cell manner. Additionally, the functions of PIGGs are often complex and involve the regulation of multiple cellular processes.

Despite these challenges, researchers have made significant progress in the study of PIGGs. They have identified the structure of many PIGGs and have shown that they have various functions, including the regulation of cell signaling pathways and the production of intracellular signaling molecules.

In addition, researchers have also shown that PIGGs are involved in the regulation of cellular processes, including cell adhesion, cell migration, and cell survival. They have also identified the role of PIGGs in the development and progression of various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

Overall, PIGG is a class of proteins that play a crucial role in cellular signaling and is involved in various cellular processes. While the study of PIGGs is still in its infancy, researchers have made significant progress in understanding their structure and function. Additionally, PIGG is a potential drug target and has been identified as a potential biomarker for various diseases. Further research is needed to fully understand the role of PIGGs in cellular signaling and their potential as drug targets.

Protein Name: Phosphatidylinositol Glycan Anchor Biosynthesis Class G

Functions: Ethanolamine phosphate transferase involved in glycosylphosphatidylinositol-anchor biosynthesis. Transfers ethanolamine phosphate to the GPI second mannose

The "PIGG Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PIGG comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

PIGH | PIGK | PIGL | PIGM | PIGN | PIGO | PIGP | PIGQ | PIGR | PIGS | PIGT | PIGU | PIGV | PIGW | PIGX | PIGY | PIGZ | PIH1D1 | PIH1D2 | PIK3AP1 | PIK3C2A | PIK3C2B | PIK3C2G | PIK3C3 | PIK3CA | PIK3CA-DT | PIK3CB | PIK3CD | PIK3CD-AS1 | PIK3CD-AS2 | PIK3CG | PIK3IP1 | PIK3IP1-DT | PIK3R1 | PIK3R2 | PIK3R3 | PIK3R4 | PIK3R5 | PIK3R6 | PIKFYVE | PILRA | PILRB | Pim Kinase | PIM1 | PIM2 | PIM3 | PIMREG | PIN1 | PIN1-DT | PIN1P1 | PIN4 | PINCR | PINK1 | PINK1-AS | PINLYP | PINX1 | PIP | PIP4K2A | PIP4K2B | PIP4K2C | PIP4P1 | PIP4P2 | PIP5K1A | PIP5K1B | PIP5K1C | PIP5K1P1 | PIP5KL1 | PIPOX | PIPSL | PIR | PIR-FIGF | PIRAT1 | PIRT | PISD | PISRT1 | PITHD1 | PITPNA | PITPNA-AS1 | PITPNB | PITPNC1 | PITPNM1 | PITPNM2 | PITPNM2-AS1 | PITPNM3 | PITRM1 | PITRM1-AS1 | PITX1 | PITX1-AS1 | PITX2 | PITX3 | PIWIL1 | PIWIL2 | PIWIL2-DT | PIWIL3 | PIWIL4 | PIWIL4-AS1 | PJA1 | PJA2 | PJVK | PKD1